InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Sunday, 03/14/2021 12:53:45 PM

Sunday, March 14, 2021 12:53:45 PM

Post# of 43382
Circumstantial evidence that the trial succeeded:

1. Mayo clinic, the location of lenzilumab's study, has had phenomenal Covid results. 1% of their patients passed away vs 3% national average. The Mayo Clinic is a top notch facility but general good medical care isn't enough to explain such success. But a wunderdrug would explain it.

2. Thermo Fisher is adding $600 million in production facilities to meet Covid demand. This article mentions Humanigen as one of two companies that could be for: https://www.fiercepharma.com/manufacturing/thermo-fisher-lays-out-600m-to-more-than-double-capacity-for-biologics-and-vaccines

3. On March 5th, two South Korean companies that HGEN has partnered with both had their stocks rise which caused HGEN's stock to shoot from $15 to $22 in premarket trading. Insider information has many ways to leak. HGEN talking to our partners is one way. Just because investors are in the dark doesn't mean things aren't happening behind the scenes with manufacturing and commercialization.

4. The UK study coming out confirming that targeting GM-CSF is the way to treat Covid. This is history in the making.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.